A Comparative Assessment of Ocular Prostheses Motility in Atrophia Bulbi Versus Implanted Anophthalmic Sockets (A Randomized Controlled Clinical Trial)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202306612520344

Enrollment

Registered

2023-06-20

Start date

2023-05-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Customized Atrophia

Ready made Atrophia

Customized Implanted

Ready made Implanted

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with unilateral missing eye with either atrophia bulbi or implanted anopthalamic socket. Have enough ocular bed to accommodate the ocular prosthesis. At least 15 days after surgery to allow complete healing of the socket.

Exclusion criteria

Exclusion criteria: Patients under steroid therapy or those under radio or chemotherapy. Patients having eye lid deformity. History of psychological disorder. systemic disease. eye infection

Design outcomes

Primary

Measure	Time frame
Ocular motility	—

Secondary

Measure	Time frame
Patient satisfaction score	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026